Tarsa Therapeutics' Debt - III Round

Tarsa Therapeutics raised a round of funding on July 14, 2016.

Tarsa Therapeutics develops therapies for the treatment and prevention of osteoporosis and related bone diseases. The company is developing OSTORA, an oral formulation of calcitonin for the treatment …

Articles about Tarsa Therapeutics' Debt - III Round: